Literature DB >> 23030323

Viral latency and potential eradication of HIV-1.

Kenneth A Matreyek1, Ilker Oztop, Eric O Freed, Alan Engelman.   

Abstract

Although HAART can suppress plasma viral loads to undetectable levels, individuals infected with HIV-1 harbor latent reservoirs of integrated proviruses that re-emerge upon the cessation of drug treatment. The 2012 Keystone Symposium on Frontiers in HIV Pathogenesis, Therapy and Eradication highlighted the current understanding of latent infection and new methods to activate and target these reservoirs for eradication. This report focuses on a select few aspects of the discussion, including the extent that ongoing replication might contribute to the persistent viral reservoir, recent advances in activating the expression of latent proviruses, progress in developing effective animal models and potential avenues to eradicate the cells that constitute the latent reservoir.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23030323      PMCID: PMC3573755          DOI: 10.1586/eri.12.68

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  20 in total

1.  HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues.

Authors:  D A Eckstein; M L Penn; Y D Korin; D D Scripture-Adams; J A Zack; J F Kreisberg; M Roederer; M P Sherman; P S Chin; M A Goldsmith
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

2.  Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.

Authors:  Xueling Wu; Tongqing Zhou; Jiang Zhu; Baoshan Zhang; Ivelin Georgiev; Charlene Wang; Xuejun Chen; Nancy S Longo; Mark Louder; Krisha McKee; Sijy O'Dell; Stephen Perfetto; Stephen D Schmidt; Wei Shi; Lan Wu; Yongping Yang; Zhi-Yong Yang; Zhongjia Yang; Zhenhai Zhang; Mattia Bonsignori; John A Crump; Saidi H Kapiga; Noel E Sam; Barton F Haynes; Melissa Simek; Dennis R Burton; Wayne C Koff; Nicole A Doria-Rose; Mark Connors; James C Mullikin; Gary J Nabel; Mario Roederer; Lawrence Shapiro; Peter D Kwong; John R Mascola
Journal:  Science       Date:  2011-08-11       Impact factor: 47.728

3.  Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

Authors:  T W Chun; L Carruth; D Finzi; X Shen; J A DiGiuseppe; H Taylor; M Hermankova; K Chadwick; J Margolick; T C Quinn; Y H Kuo; R Brookmeyer; M A Zeiger; P Barditch-Crovo; R F Siliciano
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

4.  The large intestine as a major reservoir for simian immunodeficiency virus in macaques with long-term, nonprogressing infection.

Authors:  Binhua Ling; Mahesh Mohan; Andrew A Lackner; Linda C Green; Preston A Marx; Lara A Doyle; Ronald S Veazey
Journal:  J Infect Dis       Date:  2010-11-04       Impact factor: 5.226

5.  HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.

Authors:  A S Perelson; A U Neumann; M Markowitz; J M Leonard; D D Ho
Journal:  Science       Date:  1996-03-15       Impact factor: 47.728

6.  Chromatin accessibility at the HIV LTR promoter sets a threshold for NF-κB mediated viral gene expression.

Authors:  Kathryn Miller-Jensen; Siddharth S Dey; Nhung Pham; Jonathan E Foley; Adam P Arkin; David V Schaffer
Journal:  Integr Biol (Camb)       Date:  2012-05-03       Impact factor: 2.192

7.  Genetic diversity of simian immunodeficiency virus encoding HIV-1 reverse transcriptase persists in macaques despite antiretroviral therapy.

Authors:  Mary Kearney; Jon Spindler; Wei Shao; Frank Maldarelli; Sarah Palmer; Shiu-Lok Hu; Jeffrey D Lifson; Vineet N KewalRamani; John W Mellors; John M Coffin; Zandrea Ambrose
Journal:  J Virol       Date:  2010-11-17       Impact factor: 5.103

8.  Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.

Authors:  Liang Shan; Kai Deng; Neeta S Shroff; Christine M Durand; S Alireza Rabi; Hung-Chih Yang; Hao Zhang; Joseph B Margolick; Joel N Blankson; Robert F Siliciano
Journal:  Immunity       Date:  2012-03-08       Impact factor: 31.745

9.  Generation of HIV latency in humanized BLT mice.

Authors:  Paul W Denton; Rikke Olesen; Shailesh K Choudhary; Nancy M Archin; Angela Wahl; Michael D Swanson; Morgan Chateau; Tomonori Nochi; John F Krisko; Rae Ann Spagnuolo; David M Margolis; J Victor Garcia
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

10.  A quantitative basis for antiretroviral therapy for HIV-1 infection.

Authors:  Benjamin L Jilek; Melissa Zarr; Maame E Sampah; S Alireza Rabi; Cynthia K Bullen; Jun Lai; Lin Shen; Robert F Siliciano
Journal:  Nat Med       Date:  2012-02-19       Impact factor: 53.440

View more
  5 in total

Review 1.  Synthetic biology devices for in vitro and in vivo diagnostics.

Authors:  Shimyn Slomovic; Keith Pardee; James J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-24       Impact factor: 11.205

2.  Damaging the Integrated HIV Proviral DNA with TALENs.

Authors:  Christy L Strong; Horacio P Guerra; Kiran R Mathew; Nervik Roy; Lacy R Simpson; Martin R Schiller
Journal:  PLoS One       Date:  2015-05-06       Impact factor: 3.240

Review 3.  Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins.

Authors:  Sheraz Khan; Mazhar Iqbal; Muhammad Tariq; Shahid M Baig; Wasim Abbas
Journal:  Clin Epigenetics       Date:  2018-02-05       Impact factor: 6.551

4.  Development of Droplet Digital PCR-Based Assays to Quantify HIV Proviral and Integrated DNA in Brain Tissues from Viremic Individuals with Encephalitis and Virally Suppressed Aviremic Individuals.

Authors:  Hye Kyung Chung; Julian B Hattler; Jigna Narola; Harita Babbar; Yanhui Cai; Mohamed Abdel-Mohsen; Woong-Ki Kim
Journal:  Microbiol Spectr       Date:  2022-01-12

5.  Quantification of integrated HIV DNA by repetitive-sampling Alu-HIV PCR on the basis of poisson statistics.

Authors:  Ward De Spiegelaere; Eva Malatinkova; Lindsay Lynch; Filip Van Nieuwerburgh; Peter Messiaen; Una O'Doherty; Linos Vandekerckhove
Journal:  Clin Chem       Date:  2014-03-24       Impact factor: 12.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.